Viewing Study NCT05932667


Ignite Creation Date: 2025-12-25 @ 12:37 AM
Ignite Modification Date: 2025-12-25 @ 10:47 PM
Study NCT ID: NCT05932667
Status: TERMINATED
Last Update Posted: 2023-12-21
First Post: 2023-06-13
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Milademetan and Fulvestrant in GATA3-mutant, ER+HER- Advanced or Metastatic Breast Cancer
Sponsor: Institut Curie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module